Is There A Correlation Between COVID-۱۹ and Hepatitis A and Hepatitis E Serum Antibody Level?

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 119

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJP-17-1_010

تاریخ نمایه سازی: 14 بهمن 1400

Abstract:

Background & Objective: The prevalence of COVID-۱۹ and its severity have been observed to be on a lower level in underdeveloped countries with poorer standards of hygiene. This disparity may be attributed to the higher seroprevalence of other viral diseases which can result in the presence of antibodies protective against COVID-۱۹. Two of the widespread diseases in such countries are infection to hepatitis A and E viruses (HAV and HEV). In the present study, we explored the relationship between the level of antibodies against these viruses and the susceptibility to COVID-۱۹.Methods: Ninety patients were studied in two groups of controls and cases each consisting ۴۵ individuals. The cases were patients with the clinical symptoms of COVID-۱۹ and positive RT-PCR test results. The controls were individuals referred to the respiratory triage of Imam Khomeini Hospital Complex and were not demonstrating relevant clinical symptoms of COVID-۱۹ and their RT-PCR test results were negative. Levels of HAV and HEV antibodies were measured and compared in these two groups.Results: The median of HAV antibody level was ۱۳.۶ (IQR=۱۱.۵-۱۶.۹) and ۱۳.۲ (IQR =۱۰.۷-۱۴.۷) in cases and controls, respectively, showing no statistically significant difference (P = ۰.۱). Likewise, the median of HEV antibody level was ۶.۷ (IQR=۵.۳-۷.۱) and ۷.۱ (IQR=۶.۳-۷.۵) in cases and controls, respectively, which again showed no statistically significant difference (P=۰.۴۱).Conclusion: The present study was carried out in a region with a relatively high prevalence of HAV and HEV infections. Contrary to our expectations, no statistically significant relationship was observed between the levels of antibodies against these viruses and the susceptibility to COVID-۱۹. Further studies with larger sample sizes and in other countries are needed to come to a definite conclusion.

Authors

Alireza Abdollahi -

Department of Pathology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Samaneh Salarvand -

Department of Pathology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Vahid Mehrtash -

Department of Pathology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Bita Jafarzadeh -

Department of Pathology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Reza Ghalehtaki -

Radiation Oncology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran

Saeed Nateghi -

Department of Cardiology, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • WHO Director-General's opening remarks at the media briefing on COVID-۱۹-۱۱ ...
  • COVID-۱۹ CORONAVIRUS PANDEMIC [updated September ۲۶, ۲۰۲۰. Available from: https://www.worldometers.info/coronavirus/ ...
  • Sarialioglu F, Apak FBB, Haberal M. Can Hepatitis A Vaccine ...
  • World Health Organization. The global prevalence of hepatitis A virus ...
  • Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, ...
  • نمایش کامل مراجع